Forecasting prostate cancer with MRI
Cancer treatment outcome is notoriously difficult to predict. The disease spreads rapidly in some and slowly in others. In some cases, the disease is destroyed after treatment, but in others, it returns even stronger and spreads. These factors and others can complicate treatment strategies.
A technique that uses MRI on patients about to undergo external-beam radiation therapy for prostate cancer may provide valuable clues as to whether the disease is likely to return and spread.
An ill-defined mass (*) of low-signal intensity in the left peripheral zone is associated with extracapsular extension (arrow) that measures 6 mm in radial diameter. This patient developed metastases 41 months after therapy. Reprinted with permission of Radiology.
Dr. Fergus V. Coakley and colleagues at the University of California, San Francisco, studied 80 test subjects with prostate cancer, each of whom underwent endorectal MR imaging with a GE Medical Systems unit. Characteristics of their baseline tumors were studied and recorded.
Investigators determined that the presence and degree of extracapsular extension (which measures the spread of cancer beyond the membrane surrounding the prostate gland) were important posttreatment indicators of the disease's future course.
Patients with an extracapsular extension of >5 mm before treatment were likely to develop future problems. Three of five patients with this level of extension developed metastases 24, 43 and 63 months after therapy. Patients with relatively large extensions may be candidates for more aggressive treatment early on.
The investigators said that their results are preliminary and that they want to examine a larger study group. Details of the research were published in the April issue of
Radiology.
LATEST NEWS
- Method Measures Trapped Qubits While Keeping Others Safe, Close
Sep 26, 2024
- Industrial Laser-Driven Neutron Source Developed for Nondestructive Assessment of Nuclear Waste
Sep 26, 2024
- Glass-Based PICs Developer Expands Following NATO-Supported Funding
Sep 25, 2024
- InZiv Appoints Vice President of R&D: People in the News: 9/25/24
Sep 25, 2024
- Ansys, TSMC, Collaborate with Microsoft on High-Speed Optical Data Transfer
Sep 25, 2024
- Collaboration, Tech Advancement Take Center Stage at Neuroscience 2024
Sep 24, 2024
- HyperLight Lands $37M to Advance Lithium Niobate Tech
Sep 24, 2024
- Integrated Photonics Companies Join Forces, Target Hybrid Solutions Supply Chain
Sep 24, 2024